WVE — Wave Life Sciences Share News
0.000.00%
- $660.71m
- $170.11m
- $42.73m
Wave Life Sciences Ltd Expected To Post A Loss Of 31 Cents A Share: Earnings Preview
Wave Life Sciences Q1 revenue jumps, beats analyst estimates
Brief: Wave Life Sciences Announces Hearing On Proposed Redomiciliation To The United States
Brief: Wave Life Sciences Announces Proposed Redomiciliation To The United States
U.S. STOCKS ON THE MOVE -Adobe, Salesforce, Stryker
U.S. STOCKS ON THE MOVE -Firefly Neuroscience, Liberty Energy, ImmunityBio
Wave Life Sciences shares plunge as data for high dose of obesity drug disappoints (updated)
Wave Life Sciences plunges after co reports early-stage obesity drug data
Wave Life Sciences shares plunge as data for high dose of obesity drug disappoints
U.S. STOCKS ON THE MOVE-Corebridge, Robinhood, Navan
Wave Life Sciences falls as obesity drug fails to show promise in early-stage trial
Brief: Wave Life Sciences Announces Acceptance Of Late-Breaking Oral Presentation On Wve-006 For Alpha-1 Antitrypsin Deficiency At The American Thoracic Society International Conference
Wave Life Sciences Q4 revenue beats analyst expectations
U.S. STOCKS ON THE MOVE-Abacus Global, McDonald's, Wave Life
Wave Life rises after regaining full rights to genetic disorder therapy from GSK
Brief: Wave Life Sciences Plans To Accelerate Regulatory Engagement With Full Control Of WVE-006
Brief: Wave Life Sciences Highlights Strategic Priorities For 2026 At The 44Th Annual J.P. Morgan Healthcare Conference Accelerating Development Of Wve-007 (Inhbe Sirna) For Obesity And Rapidly Advancing Rna Editing Portfolio
U.S. STOCKS ON THE MOVE-SharkNinja, Academy Sports and Outdoors, Adobe
U.S. STOCKS ON THE MOVE-PepsiCo, Pearson, Ally Financial